Adma Biologics reported $1.09M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Adma Biologics USD 1.09M 717K Mar/2026
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Novavax USD 303K 27K Dec/2021
Takeda JPY 87.87B 43.48B Dec/2025